Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells.

Papoutsis AJ, Borg JL, Selmin OI, Romagnolo DF.

J Nutr Biochem. 2012 Oct;23(10):1324-32. doi: 10.1016/j.jnutbio.2011.08.001. Epub 2011 Dec 23.

PMID:
22197621
2.

Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.

Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF.

J Nutr. 2010 Sep;140(9):1607-14. doi: 10.3945/jn.110.123422. Epub 2010 Jul 14.

3.
4.

The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.

Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF.

Cancer Res. 2006 Feb 15;66(4):2224-32.

5.

Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.

Romagnolo DF, Papoutsis AJ, Laukaitis C, Selmin OI.

BMC Cancer. 2015 Dec 29;15:1026. doi: 10.1186/s12885-015-2044-9.

7.

Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells.

Degner SC, Papoutsis AJ, Selmin O, Romagnolo DF.

J Nutr. 2009 Jan;139(1):26-32. doi: 10.3945/jn.108.099259. Epub 2008 Dec 3.

8.

The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.

Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI.

Mol Cell Endocrinol. 1999 Nov 25;157(1-2):105-19.

PMID:
10619402
9.

Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.

Kuo LC, Cheng LC, Lin CJ, Li LA.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):1064-73. doi: 10.1165/rcmb.2012-0497OC.

10.

The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.

Klinge CM, Kaur K, Swanson HI.

Arch Biochem Biophys. 2000 Jan 1;373(1):163-74.

PMID:
10620335
12.

Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.

Tomblin JK, Arthur S, Primerano DA, Chaudhry AR, Fan J, Denvir J, Salisbury TB.

Biochem Pharmacol. 2016 Apr 15;106:94-103. doi: 10.1016/j.bcp.2016.02.020. Epub 2016 Mar 2.

14.

Inhibition of BRCA-1 expression by benzo[a]pyrene and its diol epoxide.

Jeffy BD, Schultz EU, Selmin O, Gudas JM, Bowden GT, Romagnolo D.

Mol Carcinog. 1999 Oct;26(2):100-18.

PMID:
10506754
15.

Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.

Safe S, Wormke M, Samudio I.

J Mammary Gland Biol Neoplasia. 2000 Jul;5(3):295-306. Review.

PMID:
14973392
16.
17.

Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.

Go RE, Hwang KA, Kim CW, Byun YS, Nam KH, Choi KC.

Environ Toxicol. 2017 Oct;32(10):2225-2233. doi: 10.1002/tox.22438. Epub 2017 Jun 15.

PMID:
28618207
18.
19.

Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells.

Yoshioka H, Hiromori Y, Aoki A, Kimura T, Fujii-Kuriyama Y, Nagase H, Nakanishi T.

Toxicol Lett. 2012 Jun 20;211(3):257-65. doi: 10.1016/j.toxlet.2012.04.005. Epub 2012 Apr 15.

PMID:
22521833
20.

Supplemental Content

Support Center